Clinical Trials Browser

Phase 1/2 × Valproic Acid × Lymphoid × Clear all

NCT01622439 2018-03-12

VALFRID

Phase 1/2 Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT01295593 2012-06-07

Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell